Benicia, CA, United States of America

Monica J Kochanny

This inventor holds 27 USPTO granted patents and 4 published patent applications and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Berlex Laboratories, Inc., Schering Aktiengesellschaft, Celtaxsys, Inc.. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica J Kochanny. Retrieved from https://idiyas.com/inventor/monica-j-kochanny

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 81.5


Average Co-Inventor Count = 5.2

ph-index = 11

Forward Citations = 398(Granted Patents)


Location History:

  • San Rafael, CA (US) (1999 - 2002)
  • Benicia, CA (US) (2006 - 2022)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Diamine Derivatives
Leukotriene Inhibitors
Dihydropyridine Derivatives
Protein Kinase Inhibitors
Quinoline Antagonists
Indolinone Derivatives
Anti-Coagulants
Thio Acid Derivatives
Monocyclic N-Heterocyclics
Benzamidine Derivatives
Pharmaceutical Agents
CCR5 Receptor
27 patents (USPTO):Explore Patents

Title: Monica J Kochanny: Innovator in Pharmaceutical Chemistry

Introduction

Monica J Kochanny, located in Benicia, CA, is a prominent inventor known for her significant contributions to pharmaceutical chemistry. With an impressive portfolio of 27 patents, her work primarily focuses on innovative compounds that serve as inhibitors of leukotriene A hydrolase, contributing to advancements in treating inflammatory disorders.

Latest Patents

Among her latest inventions are two notable patents concerning diamine derivatives as inhibitors of leukotriene A hydrolase. These inventions are directed towards compounds of a particular formula, where various specified groups can be single stereoisomers or mixtures thereof. They include pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides, or prodrugs. The compounds developed by Kochanny are essential for creating pharmaceutical compositions that aim to effectively treat inflammatory disorders.

Career Highlights

Kochanny has a distinguished career with her work at reputable companies such as Berlex Laboratories, Inc. and Schering Aktiengesellschaft. Her innovative research and ingenuity in pharmaceutical formulations have solidified her reputation as a leader in the development of therapeutic agents.

Collaborations

Throughout her career, Kochanny has collaborated with notable colleagues, including Michael M Morrissey and Howard P Ng. Their collective efforts in research and development have contributed significantly to advancements in the pharmaceutical industry, particularly in drug formulation and disease treatment.

Conclusion

Monica J Kochanny's contributions to pharmacology and her extensive patent portfolio highlight her role as an influential inventor in the field. Her innovative compounds not only advance the scientific community's understanding of disease treatment but also pave the way for future breakthroughs in pharmaceutical chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…